#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15512	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2104	730.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1422	1422	C	805	C	763	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15512	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2104	730.9	0	HET	.	.	.	C207T	.	207	207	C	445	445	C	831	C,T	615,167	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28254	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3563	789.8	0	.	n	.	0	T695C	SNP	695	695	T	1093	1093	C	859	C	810	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28254	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3563	789.8	0	.	n	.	0	A1638G	SNP	1638	1638	A	2036	2036	G	937	G,A,T	874,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28254	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3563	789.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2369	2369	C	891	C	838	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28254	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3563	789.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2443	2443	A	886	A	853	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28254	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3563	789.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2995	2995	C	867	C	823	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Z_01426c	folP.WHO_Z_01426c	1	1	539	2102	folP	852	852	99.77	folP.l15.c17.ctg.1	1555	134.5	0	.	p	.	0	S68P	NONSYN	202	204	TCG	547	549	CCG	199;201;200	C;C,T;G	183;187,1;186	.	.
folP.WHO_Z_01426c	folP.WHO_Z_01426c	1	1	539	2102	folP	852	852	99.77	folP.l15.c17.ctg.1	1555	134.5	0	.	p	.	0	A204V	NONSYN	610	612	GCA	955	957	GTA	214;211;209	G;T;A	202;198;196	.	.
folP.WHO_Z_01426c	folP.WHO_Z_01426c	1	1	539	2102	folP	852	852	99.77	folP.l15.c17.ctg.1	1555	134.5	1	SNP	p	R228S	1	.	.	682	684	AGC	1027	1029	AGC	198;198;202	A;G;C	189;189;191	folP.WHO_Z_01426c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5338	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3352	158.8	1	SNP	p	S91F	1	.	.	271	273	TTC	560	562	TTC	195;198;199	T;T;C	175;177;182	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5338	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3352	158.8	1	SNP	p	D95G	1	.	.	283	285	GGC	572	574	GGC	192;190;189	G;G;C	174;172;173	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5338	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3352	158.8	1	SNP	p	G95N	0	.	.	283	285	GGC	572	574	GGC	192;190;189	G;G;C	174;172;173	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1744	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1489	117.0	1	SNP	p	G45D	0	.	.	133	135	GGC	602	604	GGC	216;216;216	G;G;C	200;201;200	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	872	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	851	100.5	0	.	n	.	0	A197.	DEL	197	197	A	522	522	A	196	A	190	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5042	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3032	165.7	1	SNP	p	D86N	0	.	.	256	258	GAC	631	633	GAC	214;212;210	G;A;C	204;192;201	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5042	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3032	165.7	1	SNP	p	R87W	0	.	.	259	261	CGT	634	636	CGT	212;212;210	C,A;G;T	201,1;201;197	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5042	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3032	165.7	1	SNP	p	R87I	0	.	.	259	261	CGT	634	636	CGT	212;212;210	C,A;G;T	201,1;201;197	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5042	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3032	165.7	1	SNP	p	S87R	1	.	.	259	261	CGT	634	636	CGT	212;212;210	C,A;G;T	201,1;201;197	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5042	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3032	165.7	1	SNP	p	S88P	0	.	.	262	264	TCC	637	639	TCC	210;212;215	T;C;C	196;199;202	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4350	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2599	166.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1553	1555	GGC	201;199;198	G;G;C	198;193;191	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4146	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2274	180.8	1	SNP	p	A311V	0	.	.	931	933	GCC	1142	1144	GCC	257;255;253	G;C;C	241;239;235	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4146	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2274	180.8	1	SNP	p	I312M	1	.	.	934	936	ATG	1145	1147	ATG	250;249;247	A;T;G	238;234;232	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4146	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2274	180.8	1	SNP	p	V316T	1	.	.	946	948	ACC	1157	1159	ACC	237;238;239	A;C;C	221;224;222	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4146	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2274	180.8	1	SNP	p	T316P	0	.	.	946	948	ACC	1157	1159	ACC	237;238;239	A;C;C	221;224;222	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4146	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2274	180.8	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1658	1660	ACC	203;206;210	A;C;C	188;189;195	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4146	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2274	180.8	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1712	1714	GCG	216;214;215	G;C;G	198;196;199	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4146	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2274	180.8	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1712	1714	GCG	216;214;215	G;C;G	198;196;199	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4146	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2274	180.8	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1835	1837	GGT	177;178;181	G;G;T	169;171;170	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4146	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2274	180.8	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1844	1846	AGC	170;167;164	A;G;C	161;158;153	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4146	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2274	180.8	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1862	1864	CCG	146;149;152	C,CGG;C,G;G	118,1;119,1;122	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5938	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3142	188.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1573	1575	CCG	217;221;221	C;C;G	189;200;201	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2084	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1643	125.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	513	513	C	146	C	135	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3230	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1888	170.4	1	SNP	p	G120K	1	.	.	358	360	AAG	820	822	AAG	256;255;258	A;A;G	238;242;238	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3230	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1888	170.4	1	SNP	p	N121D	0	.	.	361	363	AAC	823	825	AAC	256;256;259	A;A;C,A	241;241;242,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3230	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1888	170.4	1	SNP	p	A121N	1	.	.	361	363	AAC	823	825	AAC	256;256;259	A;A;C,A	241;241;242,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11476	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4767	239.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1448	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1093	131.2	1	SNP	p	V57M	1	.	.	169	171	ATG	481	483	ATG	294;296;296	A;T;G	286;284;286	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
